Connect with us

Hi, what are you looking for?

Gain That FlavourGain That Flavour

Editor's Pick

Can The China Strength Last Week Be Sustained?

China’s Shanghai Composite Index ($SSEC) surged higher last week by roughly 13%, which was one of its largest 1-week gains over the past decade. There were solid economic reasons for the surge as China’s central bank approved measures to accelerate recent sluggish growth. The People’s Bank of China on Tuesday announced plans to lower borrowing costs, inject more funds into the economy, and ease households’ mortgage repayment burdens. Despite these fundamental positives for the China economy, I’d argue that the index remains challenged technically, however, as overhead price resistance and trendline resistance suggest the most difficult levels to overcome remain:

The top price chart shows trendline resistance near 3100 and the most recent price high at 3200, so it’s fair to say that this 3100-3200 range is critical in the near-term. If it holds as resistance, it leaves little upside potential for China stocks from here.

The bottom panel is a 10-day rate of change (ROC) and illustrates that this recent 2-week pop is just about as strong as any over the past 10 years. The black-dotted vertical lines highlight other similar 2-week surges and, in just about every case, the initial rallies weren’t very sustainable.

From a longer-term perspective, though, this is a chart that really bothers me with respect to the Shanghai Composite’s relative performance:

Can we really trust the recent rally? This is nearly 10 years of significant underperformance by the Shanghai Composite. Will last week’s fundamental developments really change China’s long-term relative performance? I don’t know, but I need to see more than one or two weeks of strength to be convinced.

There were many stocks that benefited from this China strength and I discussed some of those and much, much more on my weekly market recap video, “China Stocks EXPLODE Higher.” Check it out and be sure to “Like” the video and “Subscribe” to our channel.

Happy trading!

Tom

You May Also Like

Editor's Pick

Michael F. Cannon President Joe Biden has touted how the Inflation Reduction Act (IRA) gives Medicare the power to negotiate lower drug prices. He...

Editor's Pick

Adam N. Michel Tax policy has taken on an outsized role in this year’s presidential campaign and was mentioned repeatedly in the recent presidential...

Editor's Pick

Jennifer J. Schulp American financial privacy has been in steady decline for more than 50 years. Regulatory frameworks, such as the Bank Secrecy Act and...

Politics

It was not only Americans tuning into the U.S. presidential debate Tuesday night as former President Donald Trump and Vice President Kamala Harris faced...